Acrivon Therapeutics, Inc. Common StockACRVNASDAQ

Revenue (LTM)

Net Income (LTM)

$-78M

+3.3% YoY

Free Cash Flow

$-65M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	-1	-1↓87.7%	0
Operating Income	-16	-33↓101.8%	-67↓105.9%	-89↓32.7%	-84↑5.7%
Net Income	-16	-31↓91.9%	-60↓93.8%	-81↓33.4%	-78↑3.3%
EBITDA	-16	-32↓100.0%	-60↓85.3%	-80↓32.9%	-84↓5.7%
EPS Diluted	-1.26	-1.42↓12.7%	-2.74↓93.0%	-2.10↑23.4%	-2.02↑3.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	100	30↓70.4%	36↑22.0%	40↑10.6%	41↑4.2%
Total Current Assets	100	132↑31.6%	130↓1.8%	182↑40.0%	120↓33.7%
Total Assets	107	181↑70.0%	138↓23.7%	197↑42.2%	130↓34.0%
Total Current Liabilities	3	7↑123.6%	13↑104.2%	17↑29.4%	16↓9.0%
Total Liabilities	130	11↓91.8%	17↑58.8%	20↑16.0%	17↓13.1%
Total Equity	-24	170↑816.0%	121↓28.9%	177↑45.9%	113↓36.4%
Total Debt	6	5↓11.9%	5↓6.4%	4↓21.5%	3↓25.7%
Net Debt	-94	-25↑73.9%	-31↓27.7%	-36↓15.3%	-39↓7.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-14	-30↓115.4%	-43↓41.6%	-66↓54.0%	-64↑3.1%
Capital Expenditure	-0	-2↓810.1%	-1↑40.5%	-3↓114.9%	-2↑39.7%
Free Cash Flow	-14	-32↓127.0%	-44↓36.1%	-68↓55.8%	-65↑4.5%
Stock-Based Comp	0	2↑339.6%	12↑431.7%	14↑23.0%	15↑3.0%
Net Change in Cash	98	-70↓171.5%	7↑109.3%	4↓45.0%	2↓53.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance